OMI Intrinsic Value Calculation – Owens & Minor, At A Crossroads As Analysts Issue ‘Hold’ Rating
June 18, 2023
🌥️Trending News
Owens & Minor ($NYSE:OMI), Inc., a leading healthcare services company, stands at a crossroads as eight analysts have recently given the company an average rating of “Hold”. This indicates that investors have grown cautious of Owens & Minor’s future performance. The company provides supply chain services to the healthcare industry, providing healthcare providers with solutions that help reduce costs and improve quality. It distributes and delivers medical-surgical products, such as disposable medical products, medical equipment and clinical supplies, as well as other products. Additionally, the company offers consulting services for healthcare providers to help them better manage their inventory and supplies. Given its strategic position within the healthcare industry, Owens & Minor has seen increased sales in recent years as healthcare providers look for ways to lower costs while maintaining quality of care.
However, analysts are increasingly concerned about the company’s ability to maintain its competitive edge in the long run. While the company continues to innovate and expand its offerings, it is unclear whether these efforts will be enough to offset any potential disruptions in the industry.
Stock Price
The stock opened the day at $21.2 and closed at $20.6, representing a 3.2% decrease from its prior closing price of $21.3. This suggests that the stock is currently in a neutral phase, as investors are uncertain about the company’s future prospects. Consequently, analysts are recommending investors to refrain from buying, selling, or holding OWENS & MINOR stock at this time. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for OMI. More…
| Total Revenues | Net Income | Net Margin |
| 10.07k | -41.31 | -0.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for OMI. More…
| Operations | Investing | Financing |
| 403.7 | -251.42 | -294.58 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for OMI. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 5.31k | 4.39k | 12.13 |
Key Ratios Snapshot
Some of the financial key ratios for OMI are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 3.9% | 12.6% | 0.9% |
| FCF Margin | ROE | ROA |
| 2.0% | 5.9% | 1.0% |
Analysis – OMI Intrinsic Value Calculation
At GoodWhale, we recently conducted an analysis of OWENS & MINOR’s financials. Our proprietary Valuation Line has determined that the fair value of OWENS & MINOR stock is around $30.4. However, the stock is currently trading at $20.6, which means it is currently undervalued by a whopping 32.3%. This presents an opportunity for investors who are willing to take a risk on this stock and buy it while it is still trading at a lower price than its true value. More…
Peers
Owens & Minor Inc is in the business of distributing medical supplies and providing related services to healthcare providers. The company operates in North America and Europe. Its competitors include Orthofix Medical Inc, Medirect Latino Inc, PT Millennium Pharmacon International Tbk.
– Orthofix Medical Inc ($NASDAQ:OFIX)
Orthofix Medical Inc is a medical device company that provides orthopedic solutions to patients worldwide. The company has a market cap of 297.51M as of 2022 and a Return on Equity of -4.8%. The company’s products are used in the treatment of various conditions, including osteoarthritis, degenerative disc disease, scoliosis, and deformities. The company’s products are sold through a network of distributors and retailers.
– Medirect Latino Inc ($OTCPK:MLTO)
PT Millennium Pharmacon International Tbk is a leading pharmaceutical company in Indonesia with a market cap of 156.7B as of 2022. The company has a strong focus on research and development, and has a strong portfolio of products. The company has a Return on Equity of 17.77%.
Summary
Owens & Minor, Inc. has recently received a “Hold” rating from eight analysts. This is a moderate assessment, as shares of the company have slightly decreased since the rating was announced. In terms of investment analysis, the company may be facing some uncertainty and is not a strong growth option at the moment.
Investors should keep in mind that opinions can change quickly in the investment world, and Owens & Minor may become a better buy at some point in the future. Before investing, investors should consider analyzing the company’s financials and comparing it to other investments.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
